The session focuses on the diagnosis and management of acute kidney injury in liver transplant candidates. Speakers focus on understanding the indications, patient selection, and outcomes of simultaneous liver-kidney transplant versus the safety net pathway and protecting kidneys after liver transplant.
To "Terli" or Not: Management of Hepatorenal Syndrome-Acute Kidney Injury
Paul Y Kwo, MD, FAASLD, Presenter
Transplant
8:20 AM - 8:35 AM
Nov
16
2024
San Diego, CA
To Dialyze or Not: Bridge to Nowhere
Kavish Patidar, DO, Presenter
Transplant
8:35 AM - 8:55 AM
Nov
16
2024
San Diego, CA
Simultaneous Liver-Kidney Transplant Versus Safety Net for Sustained Acute Kidney Injury
Mitra K Nadim, MD, Presenter
Transplant
8:55 AM - 9:15 AM
Nov
16
2024
San Diego, CA
Protecting the Kidney After Liver Transplant
Pratima Sharma, MD, MS, Presenter
Transplant
7:05 AM - 7:05 AM
Nov
16
2024
San Diego, CA
Panel Discussion and Questions and Answers
Elizabeth Carey, MD, FAASLD, Moderator
Transplant
Objectives
Review the management of hepatorenal syndrome-acute kidney injury with terlipressin and albumin, its effect on MELD score and priority for transplant, and the role of renal replacement therapy.
List the indications for simultaneous liver-kidney transplant and the safety net pathway.